ID

38074

Description

Two-Part Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Oral Dosesof the Enteric-Coated Free Base Formulation of Darapladib (SB-480848) ina Dose Rising Fashion and to Evaluate the Safety, Tolerability and Pharmacokinetics of Darapladib when Co-administered with Ketoconazole in Healthy Adult Subjects. There are 4 parts to this study: Screening, Part A, Part B, and Follow-Up. Part A contains 2 Sessions per day for day 1-10, Part B contains 1 Session per day for day 1-14. Each itemgroup contains information when it should be filled out. The itemgroups of the non-serious and serious adverse event forms contain additional information on the definition of a serious/non-serious adverse event.

Keywords

  1. 9/15/19 9/15/19 -
Copyright Holder

GlaxoSmithKline

Uploaded on

September 15, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Darapladib Evaluation Case Report Form GSK LPL107988

Concomitant Medication

Administrative documentation
Description

Administrative documentation

Subject Identifier
Description

Subject Identifier

Data type

text

Alias
UMLS CUI [1]
C2348585
Visit Date
Description

Visit Date

Data type

date

Alias
UMLS CUI [1]
C1320303
Concomitant medications
Description

Concomitant medications

Alias
UMLS CUI-1
C2347852
Were any concomitant medications taken by the subject prior to dosing and/or during the study?
Description

If Yes, record each medication on a separate line using Trade Names where possible. If the medication is related to a Non-Serious Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.

Data type

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C0008976
UMLS CUI [2,1]
C2347852
UMLS CUI [2,2]
C0347984
UMLS CUI [2,3]
C0008976
Concomitant medications information
Description

Concomitant medications information

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C1533716
Drug Name
Description

Drug Name

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0027365
Unit Dose
Description

Unit Dose

Data type

float

Alias
UMLS CUI [1]
C2826646
Units
Description

Units

Data type

text

Alias
UMLS CUI [1]
C2826767
Frequency
Description

Frequency

Data type

float

Alias
UMLS CUI [1]
C2826654
Route
Description

Route of administration

Data type

text

Alias
UMLS CUI [1]
C2826730
Reason for medication
Description

Reason for medication

Data type

text

Alias
UMLS CUI [1]
C2826696
Start Date and Time
Description

Start Date and Time

Data type

datetime

Alias
UMLS CUI [1]
C2826734
UMLS CUI [2]
C2826740
Taken prior to study
Description

Taken prior to study

Data type

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0332152
UMLS CUI [1,3]
C0008976
Stop Date and Time
Description

Stop Date and Time

Data type

datetime

Alias
UMLS CUI [1]
C2826744
UMLS CUI [2]
C2826659
Ongoing medication?
Description

Ongoing medication

Data type

boolean

Alias
UMLS CUI [1]
C2826666

Similar models

Concomitant Medication

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative documentation
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Visit Date
Item
Visit Date
date
C1320303 (UMLS CUI [1])
Item Group
Concomitant medications
C2347852 (UMLS CUI-1)
Concomitant medications
Item
Were any concomitant medications taken by the subject prior to dosing and/or during the study?
boolean
C2347852 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C2347852 (UMLS CUI [2,1])
C0347984 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])
Item Group
Concomitant medications information
C2347852 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
Drug Name
Item
Drug Name
text
C2347852 (UMLS CUI [1,1])
C0027365 (UMLS CUI [1,2])
Unit Dose
Item
Unit Dose
float
C2826646 (UMLS CUI [1])
Units
Item
Units
text
C2826767 (UMLS CUI [1])
Frequency
Item
Frequency
float
C2826654 (UMLS CUI [1])
Route of administration
Item
Route
text
C2826730 (UMLS CUI [1])
Reason for medication
Item
Reason for medication
text
C2826696 (UMLS CUI [1])
Start Date and Time
Item
Start Date and Time
datetime
C2826734 (UMLS CUI [1])
C2826740 (UMLS CUI [2])
Taken prior to study
Item
Taken prior to study
boolean
C2347852 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Stop Date and Time
Item
Stop Date and Time
datetime
C2826744 (UMLS CUI [1])
C2826659 (UMLS CUI [2])
Ongoing medication
Item
Ongoing medication?
boolean
C2826666 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial